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Abstract
Introduction: Inflammatory breast cancer (IBC) is characterized by an apparent geographical distribution in
incidence, being more common in North Africa than other parts of the world. Despite the rapid growth of
immigrants to the United States from Arab nations, little is known about disease patterns among Arab Americans
because a racial category is rarely considered for this group. The aim of this study was to advance our
understanding of the burden of IBC in Arab ethnic populations by describing the proportion of IBC among
different racial groups, including Arab Americans from the Detroit, New Jersey and California Surveillance,
Epidemiology and End Results (SEER) registries.
Methods: We utilized a validated Arab surname algorithm to identify women of Arab descent from the SEER
registries. Differences in the proportion of IBC out of all breast cancer and IBC characteristics by race and
menopausal status were evaluated using chi-square tests for categorical variables, t-tests and ANOVA tests for
continuous variables, and log-rank tests for survival data. We modeled the association between race and IBC among
all women with breast cancer using hierarchical logistic regression models, adjusting for individual and census
tract-level variables.
Results: Statistically significant differences in the proportion of IBC out of all breast cancers by race were evident. In
a hierarchical model, adjusting for age, estrogen and progesterone receptor, human epidermal growth receptor 2,
registry and census-tract level education, Arab-Americans (OR=1.5, 95% CI=1.2,1.9), Hispanics (OR=1.2, 95%
CI=1.1,1.3), Non-Hispanic Blacks (OR=1.3, 95% CI=1.2, 1.4), and American Indians/Alaskans (OR=1.9, 95% CI=1.1, 3.4)
had increased odds of IBC, while Asians (OR=0.6, 95% CI=0.6, 0.7) had decreased odds of IBC as compared to
Non-Hispanic Whites.
Conclusions: IBC may be more common among certain minority groups, including Arab American women.
Understanding the descriptive epidemiology of IBC by race may generate hypotheses about risk factors for this
aggressive disease. Future research should focus on etiologic factors that may explain these differences.
Keywords: Inflammatory breast cancer, Arab, Race, Hierarchical logistic regression
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Background
Inflammatory breast cancer (IBC) is an aggressive type
of breast cancer with poor prognosis. IBC is character-
ized by an apparent non uniform geographical distribu-
tion in incidence, being more common in North Africa
than in other parts of the world. Prior studies have
demonstrated that between 1-6% of all breast cancers
in the United States are IBC (Taylor & Meltzer 1938;
Haagensen 1971; Levine et al. 1985), while the propor-
tion of IBC in Tunisia has been reported as high as 55%
(Mourali et al. 1980) with more recent estimates sug-
gesting that IBC represents 5-7% of all breast cancers in
Tunisia (Boussen et al. 2008). A population-based study
in Egypt established that 11% of all breast cancers there
were IBC, which is considerably higher than what is
reported in most of the western world (Soliman et al.
2009). In addition to geographical variability in IBC oc-
currence, studies also suggest that substantial disparities
in IBC occurrence may exist by age, race, and socioeco-
nomic status (SES) (Levine et al. 1985; Chang et al.
1998a; Hance et al. 2005). Studies in the U.S. have
demonstrated a higher incidence rate of IBC among Af-
rican American women as compared to White women,
and comparable rates among Hispanic and non-Hispanic
white women; moreover, a younger mean age of IBC
onset among Hispanic women as compared to White
and African American women has been noted (Hance
et al. 2005; Wingo et al. 2004; Il'yasova et al. 2011). Fur-
thermore, socioeconomics may play an important role in
IBC risk, as is evident in the rural predominance of the
disease in Tunisia where the SES is generally lower than
in urban regions (Mourali et al. 1980; Boussen et al.
2008; Boussen et al. 2010a), and also in the comparison
of IBC in North African migrants to France compared
with French women living in the same region (Le et al.
2005). A steady decline in IBC cases has been reported
appearing in parallel with improved socioeconomic con-
ditions in Tunisia (Boussen et al. 2010b), lending further
support for the association between SES and IBC.
Arabic immigrants represent a rapidly growing popu-
lation in the United States (Zogby 1990; Abraham &
Abraham 1983), although the overall size of the Arab
American population is highly debated (Jamil et al.
2009). While Arab Americans live in all fifty states, it is
estimated that the majority reside in California,
Michigan, New York, Florida, and New Jersey (Arab
American Institute 2004). Despite the rapid growth of
immigrants from Arab nations, little is known about dis-
ease patterns among this group because a racial/ethnic
category is often not designated for this group, resulting
in broad inclusion of Arabs into the White racial cat-
egory. Previous studies have constructed and utilized
surname databases to identify Arab immigrants and to
describe relative proportions of different cancer types
among this population (Nasseri 2007; Schwartz et al.
2004; Lauderdale 2006). A recent study in the Detroit
SEER registry demonstrated increased odds of IBC
among Arab Americans as compared to European-
Americans (Alford et al. 2009); however, this estimate
failed to reach statistical significance, perhaps due to the
small sample size.
The aim of this study was to examine the occurrence
of IBC among Arab Americans in the California, Detroit
and New Jersey SEER registries. These registries have
the largest expected Arab American populations and
were included to maximize the number of Arab Ameri-
cans in our sample. Understanding the descriptive epi-
demiology of IBC in Arab Americans may generate
hypotheses about potential risk factors for this aggressive
disease.
Methods
The study population consisted of all women diagnosed
with primary invasive breast cancer from 1988–2008 in
the SEER population-based cancer registries in Detroit,
New Jersey and California. For each case, the following
information from routinely collected registry data was
obtained: age at diagnosis, race, hormonal receptor sta-
tus, tumor characteristics, staging, and survival time.
The Reporting Recommendations for Tumor Marker
Prognostic Studies (REMARK) guidelines were followed
in the reporting of the hormonal receptor results
(McShane et al. 2005). Assay results for estrogen and
progesterone receptor status, prior to neoadjuvant ther-
apy, if available, were abstracted by the SEER registries
from the medical record (Johnson & Adamo 2008).
Cases where the assay was not performed or was border-
line or undetermined were not included in our logistic
regression model of marker status by race/ethnicity. The
percent of individuals over 25 years of age without a
high school diploma within a census tract was also
obtained from the SEER registries. We categorized the
census-tract level education as high, middle, and low
based on tertiles of the overall distribution of this vari-
able in our dataset as follows: High education = <10.85%
less than high school graduate; Middle education =
>10.85% less than high school graduate and <21.97% less
than high school graduate; Low education = >21.97%
less than high school graduate. Women 50 years of age
and older were considered post-menopausal while those
under the age of 50 were considered pre-menopausal.
Data were stripped of all personal identifiers, and the
analyses were approved by the University of Michigan
Institutional Review Board, Wayne State University
Human Investigations Committee, the California Protec-
tion for Human Subjects Committee, and the Institu-
tional Review Board at the University of Medicine and
Dentistry of New Jersey.
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Using a validated Arabic name algorithm, we identified
Arab American women based on maiden name or sur-
name if maiden name was not available in the National
Cancer Institute’s SEER registry data from Detroit, New
Jersey and California in 1988–2008. The Arabic name
algorithm was created by compiling names from vital
statistics records that indicated Arab ethnicity, Arab
community group name rosters, and other publicly avail-
able name lists. There are over 13,000 surnames on the
lists and they have been reviewed multiple times by Arab
community members for accuracy. Several quality con-
trol measures were used in creating the lists (Schwartz
et al. 2004), and a recent telephone validation survey
demonstrated that the lists have a 91% positive predict-
ive value [Schwartz et al, in press]. The SEER race codes
and Spanish and Hispanic origin variable based on the
direct identification component of NAACCR Hispanic
Identification Algorithm were utilized to identify the
other racial categories in our study. We then compared
the proportion of IBC out of all breast cancers and the
tumor characteristics and survival time among Arab
American, non-Hispanic White (NHW), non-Hispanic
Black (NHB), Hispanic, Asian, and American Indian/Al-
askan women.
IBC cases were identified using comprehensive coding
including ICD-O 8530, which requires pathologic plug-
ging of the dermal lymphatics with tumor emboli, or the
extent of disease (EOD) codes EOD-E70 or EOD-E 710–
730 or AJCC T4d. This comprehensive case definition of
IBC has been utilized in recent publications on IBC
from SEER registries (Schlichting et al. 2011; Schairer
et al. 2011).
We evaluated differences in the proportion of IBC out
of all breast cancer and IBC characteristics by race and
menopausal status using chi-square tests or Fisher's
exact test for categorical variables and t-tests and
ANOVA tests for continuous variables. Log-rank tests
were utilized to evaluate differences in IBC survival by
race and menopausal status. Logistic regression models
were utilized to characterize differences in tumor marker
status among the IBC cases by race. We then modeled
the association between race and IBC among all women
with breast cancer using hierarchical logistic regression
models, adjusting for age, tumor marker status, registry
and the derived census tract-level education variable.
This model accounts for the hierarchical structure and
clustering of the data by specifying random effects for
the individual-level and census tract-level variables. Con-
founders were included in the model based upon our
prior knowledge. Furthermore, potential confounders
that resulted in at least a 10% change-in-estimate criteria
between the crude and adjusted measures were included
in the model. We tested for interactions between race
and each of the characteristics; significant interactions
were retained in the model along with their main effects.
The hierarchical logistic model was restricted to the
years 1999–2008, where tumor marker status informa-
tion was more regularly reported in SEER. Data analysis
was performed using SAS version 9.0 (SAS Institute Inc,
Cary, NC); P≤.05 was used to determine statistical
significance.
Results
A total of 621,465 female breast cancer cases were
included in our study population, of which 9,135 (1.47%)
were considered IBC. As shown in Table 1, Hispanic
women had the lowest mean age at IBC diagnosis of
52.6 years. Arab Americans (58.5 years) and NHW
women (60.1 years) were diagnosed with IBC at older
ages compared to the other racial groups in our study.
Compared to NHW women, all other racial categories
were more likely to be diagnosed with estrogen receptor
(ER) negative and progesterone receptor (PR) negative
tumors, and were more likely to be diagnosed when pre-
menopausal (Table 1), although this trend was the least
pronounced among the Arab American women. Arab
Americans had the longest mean survival time of 50.5
months, while American Indian/Alaskan natives had the
shortest mean survival of 24.8 months (p<.0001). Statis-
tically significant differences in the proportion of IBC
out of all breast cancers by racial/ethnic group were evi-
dent; 2.91% IBC among American Indian/Alaskan, 2.3%
IBC among Hispanics, 2.2% IBC among NHB, 1.7% IBC
among Arab Americans, 1.3% IBC among NHW and
1.2% IBC among Asians (Table 2).
In a hierarchical model, adjusting for age, ER, PR,
human epidermal receptor 2 (Her2), registry and census
tract-level education, Arab-Americans (OR=1.5, 95%
CI=1.2, 1.9), NHB (OR=1.3, 95% CI=1.2, 1.4), Hispanics
(OR=1.2, 95% CI=1.1,1.3), and American Indians/Alaskans
(OR=1.9, 95% CI=1.1, 3.4) all had increased odds of IBC
diagnosis as compared to NHW, while Asians had a
decreased odds of IBC as compared to NHW (OR=0.6,
95% CI=0.6, 0.7) (Table 3). Interaction terms for race by
each characteristic were evaluated in the hierarchical
model. The interaction term for race by ER was statisti-
cally significant (p<.0001) and was included in the final
model. NHW women were less likely to have ER/PR nega-
tive tumors as compared to all other racial categories, al-
though this difference was not statistically significant
among Arab-Americans and American Indian/Alaskan
natives (Table 4). Hispanic (45.8%) and American Indian/
Alaskan (42.1%) women had the highest percentage of
IBC cases diagnosed in the premenopausal years as com-
pared to the other racial groups, while only 26.6% of Arab
American women were diagnosed in premenopausal years
(Table 5). Premenopausal IBC cases were more likely to be
ER/PR negative, and in the low education category as
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compared to postmenopausal IBC cases. Further, preme-
nopausal women had a significantly improved mean sur-
vival of 96.4 months as compared to 59.2 months among
postmenopausal women (p<.0001) (Table 5).
Discussion
This study demonstrated significant differences in the
presentation of IBC and the proportion of IBC out of all
breast cancers by racial group. Our finding of a younger
age at onset of IBC among Hispanic women as com-
pared to NHB and NHW women is consistent with a
previous study (Wingo et al. 2004). Almost half of the
IBC cases among Hispanic and American Indian/
Alaskan natives occurred before the age of 50. While
previous studies suggest that IBC rates are similar be-
tween non-Hispanic whites and Hispanic women, we
found the proportion of IBC out of all breast cancers
was significantly higher among Hispanic women as com-
pared to NHW. If the IBC rates are in fact similar be-
tween these women, our results may be explained by
differences in the trends of non-IBC breast cancer be-
tween groups, as non-IBC breast cancer incidence rates
have remained stable after declining 7% from 2002 to
2003 (American Cancer Society 2012; DeSantis et al.
2011). These findings highlight the limitation of using
proportion of IBC out of all breast cancer instead of IBC
Table 1 Inflammatory breast cancer characteristics by race
Arab NHW a NHB b Hispanic Asian AI_Alc p-value
(n=94) (n=6,035) (n=1,085) (n=1,415) (n=449) (n=19)
n (%) n(%) n(%) n(%) n(%) n(%)
Estrogen Receptor d
Positive 38 (42.2%) 2,219 (39.3%) 332 (32.1%) 491 (36.4%) 156 (36.7%) 7 (36.8%) 0.0070
Negative 36 (40.0%) 1,833 (32.4%) 391 (37.7%) 474 (35.1%) 156 (36.7%) 7 (36.8%)
Unknown 16 (17.8%) 1,598 (28.3) 313 (30.2%) 384 (28.5%) 113 (26.6%) 5 (26.3%)
Progesterone Receptor d
Positive 23 (25.6%) 1,762 (31.2%) 252 (24.3%) 380 (28.2%) 117 (27.5%) 4 (21.1%) 0.0003
Negative 50 (55.5%) 2,195 (38.8%) 453 (43.7%) 570 (42.2%) 189 (44.5%) 10 (52.6%)
Unknown 17 (18.9%) 1,693 (30%) 331 (32%) 399 (29.6%) 119 (28%) 5 (26.3%)
Combined Hormonal Status e
ER+ PR+ 20 (27.4%) 1,597 (40.6%) 222 (31.6%) 336 (35.7%) 108 (35.3%) 4 (28.6%) 0.0002
ER+ PR- 17 (23.3%) 538 (13.7%) 98 (14%) 136 (14.4%) 44 (14.4%) 3 (21.4%) 0.0948
ER- PR+ 3 (4.1%) 158 (4.0%) 28 (4%) 42 (4.5%) 9 (2.9%) 0 (0%) 0.8900
ER- PR - 33 (45.2%) 1,642 (41.7%) 354 (50.4%) 428 (45.4%) 145 (47.4%) 7 (50.0%) 0.0129
Her-2 Receptor f
Positive 14 (29.2%) 594 (21.9%) 94 (17.9%) 248 (29.9%) 83 (31.1%) 2(18.2%) <0.0001
Negative 12 (25.0%) 906 (33.4%) 166 (31.7%) 310 (37.3%) 91 (34.1%) 5 (45.5%)
Unknown 22 (45.8%) 1,209 (44.6%) 264 (50.4%) 272 (32.8%) 93 (34.8%) 4 (36.3%)
Education g
High 36 (38.3%) 2,233 (37.0%) 183 (16.9%) 198 (14.0%) 128 (28.5%) 3 (15.8%) <0.0001
Middle 30 (31.9%) 2,021 (33.5%) 249 (23.0%) 262 (18.5%) 127 (28.3%) 8 (42.1%)
Low 28 (29.8%) 1,781 (29.5%) 653 (60.2%) 955 (67.5%) 194 (43.2%) 8 (42.1%)
Menopausal Status
Pre (<50 yr) 25 (26.6%) 1,565 (25.9%) 389 (35.9%) 648 (45.8%) 162 (36.1%) 8 (42.1%) <0.0001
Post (≥50 yr) 69 (73.4%) 4,470 (74.1%) 696 (64.1%) 767 (54.2%) 287 (63.9%) 11 (57.9%)
%No Education g 18.6 (15) 17.7 (13) 29.4 (18) 35.2 (21) 23.7 (17) 28.8 (18) <0.0001
Age at diagnosis 58.5 (11.7) 60.1 (14.6) 56.2 (14.5) 52.6 (14) 54.0 (12.5) 54.8 (12.7) <0.0001
Survival (months) 50.5 (51.3) 47.6 (49.3) 33.2 (37.5) 43.1 (44.2) 49.7 (47.4) 24.8 (25.7) <0.0001
a NHW=Non-Hispanic White.
b NHB = Non-Hispanic Black.
cAI_Al = American Indian/Alaskan native.
d Sample size for ER and PR for cases diagnosed 1990–2008 only (NHW=5650, NHB=1036, Hispanic=1349, Arab=90, Asian=425, AI_Al=19).
e Combined hormonal status based only on non-missing data from 1990–2008 (sample size for NHW = 3935, NHB=702, Hispanic =942 , Arab=73, Asian=306, Al_AI=14).
f Sample size for HER2 for cases diagnosed 1999–2008 (NHW=1209, NHB=524, Hispanic=830, Arab=48, Asian=267, Al_AI=11).
g% No Education (25 years of age or older without a high school diploma) and Education (tertiles of distribution) based on census tract-level information.
*ANOVA test for continuous variables, chi-sq for categorical (or Fisher's exact test for cell counts <5), log-rank test for Survival.
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incidence rates to evaluate racial disparities. If denomin-
ator data were available for the Arab population in the
SEER geographic areas, we would have been able to cal-
culate age-standardized incidence rates for the racial
groups.
The racial disparities in IBC occurrence described in this
study may be partially explained by risk factors for IBC
that were not adequately controlled for in our analysis.
For example, several reproductive factors have been
found to be associated with IBC occurrence in previous
studies. IBC patients have been reported to have a
younger age at menarche and a younger age at first live
birth as compared to non-inflammatory breast cancer
and non breast cancer patients (Mourali et al. 1980;
Chang et al. 1998a; Boussen et al. 2010b; Chang et al.
1998b; Le et al. 2006; Levine 2004). Further, duration of
breast feeding exceeding 24 months was found to be sig-
nificantly associated with IBC in one study (Le et al.
2005). If these reproductive factors are in fact risk fac-
tors for IBC and differ by race, as we may suspect
(Anderson et al. 2005; Hall et al. 2005), it could possibly
explain some of the racial disparities in IBC occurrence
observed in our study. In addition to reproductive risk
factors for IBC, obesity has been shown to be a risk fac-
tor for premenopausal IBC but not for postmenopausal
non-IBC in one study (Levine & Venerose 2005), while
another study demonstrated that IBC patients had sig-
nificantly higher BMI than both non-IBC patients and
non-breast cancer patients irrespective of menopausal
status (Chang et al. 1998b). Finally, we utilized census-
tract level information on education as a proxy for
socioeconomic status, to account for the contextual ef-
fect of living in a community with lower educational at-
tainment, since individual-level education and SES
information was unavailable in our dataset. According to
2010 Census information, African-Americans and Hispa-
nics have similar rates of poverty, which are approxi-
mately threefold greater than Whites (The US Census
Bureau 2010). Without detailed information on repro-
ductive factors, obesity and individual-level SES available
in the SEER dataset, we cannot control for these factors
in our analysis. Therefore, it is possible that some of the
difference in proportion of IBC by race may be explained
by residual differences in risk factors that are not
accounted for in our study. It has been suggested that
the effect of certain risk factors for IBC may differ
according to menopausal status (Levine & Venerose
2005). This was apparent in urban–rural differences in
IBC cases in Tunisia seen only in premenopausal
patients (Mourali et al. 1980), and in obesity as a
risk factor for premenopausal women only (Levine &
Venerose 2005). Therefore, we stratified our hierarchical
model by derived menopausal status to evaluate whether
menopause modified the association between race and
IBC. Our derived menopausal status variable has been
shown to be a robust indicator of actual menopausal sta-
tus (Phipps et al. 2010; Morabia & Flandre 1992), and
has been utilized in several population-based studies on
breast cancer (Anderson et al. 2003; Anderson et al.
2004). Stratifying our results for the effect of race
on IBC, we found that menopausal status did not
significantly modify the effect of race on IBC (data not
shown); however, we did find significant differences in
disease characteristics between pre-menopausal and
post-menopausal IBC cases. The differences in education
and hormonal receptor status may provide evidence for
differing etiologies for premenopausal and postmeno-
pausal IBC cases, and this should be considered in
future research on IBC risk factors. However, it is im-
portant to note that we used age as a proxy for meno-
pausal status. Thus, differences in IBC occurrence by
menopausal status in our analysis may simply reflect the
effect of age and not necessarily an effect of menopause.
Early treatment is critical to improve outcomes for IBC.
Our study found improved survival among Arab Americans
IBC cases compared to all other racial categories. This
Table 2 Proportion of IBC out of all breast cancers by
race and registry
Race All Breast Cancer IBC %IBC p-value
All Races combined 621,465 9,135 1.47% -
NHW 462,717 6,035 1.30% <0.0001
NHB 49,980 1,085 2.17%
Hispanic 61,062 1,415 2.32%
Arab-American 5,539 94 1.70%
Asian 37,085 449 1.21%
American Indian/Alaskan 652 19 2.91%
Other 506 6 1.19%
Unknown 3,924 32 0.82%
New Jersey Registry 135,764 1,333 0.98% <0.0001
Detroit Registry 60,412 808 1.34%
California Registry 425,289 6,994 1.64%
*P-value from chi square test.
Table 3 Odds ratios (95% CI) for IBC by race
Race Crude Model Age-Adjusted HLMa
Non-Hispanic White 1.0 (ref) 1.0 (ref) 1.0 (ref)
Non-Hispanic Black 1.8 (1.7, 2.0) 1.7 (1.6, 1.8) 1.3 (1.2, 1.4)
Hispanic 1.7 (1.6, 1.8) 1.5 (1.4, 1.6) 1.2 (1.1, 1.3)
Arab-American 1.4 (1.1, 1.8) 1.3 (1.1, 1.6) 1.5 (1.2, 1.9)
Asian 0.9 (0.8, 0.9) 0.8 (0.7, 0.8) 0.6 (0.6, 0.7)
American Indian/Alaskan 2.2 (1.4, 3.5) 2.0 (1.2, 3.2) 1.9 (1.1, 3.4)
Other 0.9 (0.3, 2.3) 0.8 (0.3, 2.0) 1.1 (0.3, 3.8)
Unknown 0.6 (0.4, 0.9) 0.6 (0.4, 0.9) 0.9 (0.6, 1.3)
a=Hierarchical logistic regression model adjusted for age, ER, PR, Her2, registry
and census tract-level education and included interaction term between race
and ER.
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finding was also recently reported in non-IBC cases among
Arab Americans (Alford et al. 2009). American Indian/Al-
askan natives were found to have the shortest mean sur-
vival time, and efforts to reach these populations for early
treatment of disease should become a priority. We also
found improved survival times among premenopausal IBC
cases as compared to postmenopausal women, which is not
entirely surprising due to the implications of age on
survival. These survival disparities need to be addressed
and may reflect a lack of early detection, lack of timely and
aggressive treatment, and access to care. Without complete
treatment information including chemotherapy in our data-
set, we are unable to explore these survival differences in
more depth in this study.
Limitations of this study include a potential for misclassifi-
cation of Arab women, especially where the maiden name
Table 4 Odds ratios (95% CI) for marker status at IBC diagnosis by race
Marker a NHW NHB Hispanic Arab Asian AI_Al
ER+PR+ 1.0 0.72 (0.61, 0.84) 0.87 (0.76, 0.99) 0.75 (0.46, 1.2) 0.88 (0.7, 1.1) 0.74 (0.25, 2.2)
ER- PR- 1.0 1.30 (1.1, 1.5) 1.16 (1.02, 1.3) 1.45 (0.9, 2.2) 1.28 (1.04, 1.57) 1.56 (0.6, 4.0)
a ER and PR non-missing data from 1990–2008 only (sample size for NHW = 3935, NHB=702, Hispanic =942 , Arab=73, Asian=306, Al_AI=14).
Table 5 Study population characteristics of IBC cases by menopausal status (age <50 yr vs. >=50 yr)
All IBC Premenopausal IBC Postmenopausal IBC p-value
(n=9,135) (n=2811) (n=6,324)
n (%) n (%) n (%)
Race
Non-Hispanic White 6,035 (66.1%) 1,565 (25.9%) 4,470 (74.1%) <0.0001
Non-Hispanic Black 1,085 (11.9%) 389 (35.9%) 696 (64.1%)
Arab-American 94 (1%) 25 (26.6%) 69 (73.4%)
Hispanic 1,415 (15.5%) 648 (45.8%) 767
Asian 449 (4.9%) 162 (36.1%) 287 (63.9%)
American Indian/Alaskan 19 (0.2%) 8 (42.1%) 11 (57.9%)
Other 6 (0.07%) 1 (16.7%) 5 (83.3%)
Unknown 32 (0.35%) 13 (40.6%) 19 (59.4%)
Estrogen Receptor a
Positive 3,258 (37.9%) 893 (33.8%) 2,365 (39.7%) <0.0001
Negative 2,909 (33.8%) 1,017 (38.4%) 1,892 (31.7%)
Unknown 2,438 (28.3%) 735 (27.8%) 1,703 (28.6%)
Progesterone Receptor a
Positive 2,551 (29.7%) 768 (29.0%) 1,783 (29.9%) 0.17
Negative 3,480 (40.4%) 1,109 (41.9%) 2,371 (39.8%)
Unknown 2,574 (29.9%) 768 (29.0%) 1,806 (30.3%)
Her-2 Receptor b
Positive 1,042 (23.6%) 349 (27.3%) 693 (22.1%) 0.0005
Negative 1,496 (33.9%) 426 (33.4%) 1,070 (34.1%)
Unknown 1,879 (42.5%) 502 (39.3%) 1,377 (43.8%)
Education c
High 2,801 (30.7%) 814 (29.0%) 1,987 (31.4%) <0.0001
Middle 2,702 (29.6%) 756 (26.9%) 1,946 (30.8%)
Low 3,632 (39.8%) 1,241 (44.2%) 2,391 (37.8%)
% No Education c 22.1 (17) 24.1 (18.4) 21.2 (16.3) <0.0001
Age at diagnosis 58.1 (14.7) 41.7 (5.8) 65.4 (11.2) <0.0001
Survival time in months 46.5 (122.2) 96.4 (77.3) 59.2 (61.1) <0.0001
a Sample size for ER and PR for cases diagnosed 1990–2008 only (IBC=8,605, pre-menopause=2,645, post-menopause =5,960)).
b Sample size for HER2 for cases diagnosed 1999–2008 (IBC=4,417, pre-menopause=1,277, post-menopause =3,140).
c % No Education (25 years of age or older without a high school diploma) and Education (tertiles of distribution) based on census tract-level information.
* ANOVA test for continuous variables, chi-sq for categorical (or Fisher's exact test for cell counts <5), log-rank test for Survival. All statistical tests comparing
differences in premenopausal and postmenopausal IBC cases.
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was unavailable. We were unable to assess the magnitude
of this potential misclassification bias, as we did not have
access to the actual surnames within our dataset. However,
we believe that the possibility of misclassification is limited
as many Arab ancestry women keep their maiden names
upon marriage (Al-Hegelan 1980; Kayyali 2006; Kleffner
Nydell 2005), and maiden names are available for a large
proportion of the women. Another possible limitation of
this study was the lack of information on country of origin
or date of immigration to the United States. The Arab
American immigrant group is composed of individuals
from many diverse Arab nations. Without information on
country of origin, we may be missing critical information
that could explain disparities in IBC occurrence. We did
evaluate the place of birth variable in our dataset, however
this variable was missing for 42% of breast cancer cases.
Therefore, we were unable to accurately assess this factor
in our analysis. Further, we would surmise that immigrants
arriving earlier in life would be more likely to experience
cancer rates comparable to non-Arab Whites versus immi-
grants who arrived later (Zogby 1990). Without informa-
tion on time of immigration, we may be mixing the effect
of IBC occurrence between recent Arab immigrants, who
maintain certain cultural norms from their countries of ori-
gin, with Arab women who have become acculturated to
the Western lifestyle after having been born in or living in
the U.S. for a considerable amount of time. It would be
beneficial to evaluate IBC cancer occurrence by time of im-
migration among migrant groups in the U.S. in order to
understand potential environmental risk factors for the dis-
ease. A further limitation could be the use of different la-
boratories to determine hormonal receptor status in our
dataset. Additionally, the hormonal receptor data were not
routinely collected during our study period, so we do have
to be concerned about missing data for these variables. To
overcome this limitation, we restricted our analysis on ER/
PR from 1990 forward and on Her2 from 1999 forward,
when this information was more regularly reported in the
SEER registries. Lack of data on other potentially impor-
tant covariates including reproductive factors, obesity,
individual-level SES, acculturation, and urban/rural status
could lead to residual confounding in our analysis. It is also
important to consider that our data came from the Detroit
SEER, which only includes 3 counties in Michigan, while
the California and New Jersey registries are state-wide. This
could potentially affect the generalizability of our results if
we think that these registries are not representative of the
overall population of women with breast cancer in the Uni-
ted States. Finally, this is a purely descriptive analysis and
we are unable to draw causal inferences from the results.
Strengths of this study include the use of large-scale
population-based SEER registry data, which is considered
to be reliable and accurate as it meets International
Agency for Research on Cancer (IARC) standards,
ensuring a certain degree of data quality and comparability
based on a number of factors (Parkin et al. 2003). Further,
the IBC case ascertainment definition used in this study is
considered valid and is not as conservative as previous
studies requiring the pathological diagnosis of IBC. The
name algorithm to identify Arab ancestry has been con-
structed and utilized to describe relative proportion of
cancer among this population in previous studies (Nasseri
2007; Schwartz et al. 2004; Lauderdale 2006). Finally, this
study is innovative as it maximized the number of Arab
Americans represented in the study sample by applying
data from California, Detroit, and New Jersey registries.
Conclusions
Our results suggest that IBC occurrence may be more
common among certain minority groups, including Arab
American women. With the significant lack of epidemio-
logic data on IBC, this study represents important pro-
gress to our understanding of this rare and aggressive
disease. By evaluating racial disparities in IBC occur-
rence, we hope to generate further hypotheses about po-
tentially modifiable risk factors for IBC. Future research
should focus on etiologic factors that may underlie these
differences and also examine country of origin and date
of immigration to the U.S. to further understand poten-
tially modifiable risk factors for IBC.
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